BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32064771)

  • 21. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma.
    Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B
    Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bioinformatics analysis for diagnostic roles of the
    Li J; Wang H; Cao F; Cheng Y
    J Gastrointest Oncol; 2022 Oct; 13(5):2115-2131. PubMed ID: 36388667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F family play important roles in tumorigenesis.
    Li FF; Wang Y; Gu JH; Zhang YM; Liu FS; Ni ZH
    Yi Chuan; 2023 Jul; 45(7):580-592. PubMed ID: 37503582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic study on expression and prognosis of E2Fs in human colorectal cancer.
    Ma Y; Wang S; Bao J; Wang C
    Int J Clin Oncol; 2022 Feb; 27(2):362-372. PubMed ID: 34661779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression.
    Yang R; Wang M; Zhang G; Bao Y; Wu Y; Li X; Yang W; Cui H
    Br J Cancer; 2020 Oct; 123(9):1445-1455. PubMed ID: 32814835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma.
    Luo H; Tao C; Long X; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):7765-7779. PubMed ID: 34617871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics Identification of the Expression and Clinical Significance of E2F Family in Endometrial Cancer.
    Zhang Y; Wang Z; Ma J; Huo J; Li Y; Wang Y; Chen H; Shan L; Ma X
    Front Genet; 2020; 11():557188. PubMed ID: 33329696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA-damage response control of E2F7 and E2F8.
    Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
    EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E2F8 as a Novel Therapeutic Target for Lung Cancer.
    Park SA; Platt J; Lee JW; López-Giráldez F; Herbst RS; Koo JS
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26089541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of E2F transcription factor in oral cancer: Recent insight and advancements.
    Kassab A; Gupta I; Moustafa AA
    Semin Cancer Biol; 2023 Jul; 92():28-41. PubMed ID: 36924812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive bioinformatics analysis of the E2F family in human clear cell renal cell carcinoma.
    Liu ZG; Su J; Liu H; Yang XJ; Yang X; Wei Y; Zhu XY; Song Y; Zhao XC; Guo HL
    Oncol Lett; 2022 Oct; 24(4):351. PubMed ID: 36168311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma.
    Yang C; Zhang ZC; Liu TB; Xu Y; Xia BR; Lou G
    Cancer Cell Int; 2020; 20():500. PubMed ID: 33061852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1.
    Weijts BG; Bakker WJ; Cornelissen PW; Liang KH; Schaftenaar FH; Westendorp B; de Wolf CA; Paciejewska M; Scheele CL; Kent L; Leone G; Schulte-Merker S; de Bruin A
    EMBO J; 2012 Oct; 31(19):3871-84. PubMed ID: 22903062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F7 and E2F8 keep the E2F family in balance.
    Moon NS; Dyson N
    Dev Cell; 2008 Jan; 14(1):1-3. PubMed ID: 18194644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma.
    Lin S; Yu X; Yan H; Xu Y; Ma K; Wang X; Liu Y; Xie A; Yu Z
    Medicine (Baltimore); 2024 Jan; 103(3):e34342. PubMed ID: 38241554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.